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The pattern of motor, behavioral and cognitive symptoms in
Huntington’s disease (HD) implicates dysfunction of basal-
ganglia-thalamo-cortical circuits. This study explored if cognitive
performance in HD is correlated with localized cerebral changes.
Psychomotor functions were investigated by verbal fluency, Stroop
color word and Digit Symbol tests in 44 HD patients and 22 con-
trols. Three-dimensional magnetic resonance imaging (MRI) data
were analyzed with regard to regional gray matter changes by use
of the observer-independent whole-brain-based approach of voxel-
based morphometry (VBM). Using statistical parametric mapping,
the MRI data of the HD patients were analyzed in an ANCOVA
including the individual results of the neuropsychological tests.
Besides striatal areas, symmetrical regional atrophy of the thal-
amus was found to co-vary significantly with cognitive performance
(P < 0.001, corrected for multiple comparisons). In particular,
thalamic subnuclei projecting to prefrontal areas (dorsomedial
subnucleus) and connected to the striatum (centromedian/
parafascicular and ventrolateral nuclear complex) displayed volume
loss, in agreement with neuropathological studies. These results
suggest that thalamic degeneration contributes in an important way
to the impairment of executive function in early HD. Patients who
are impaired in executive tests display structural double lesions of
the basal-ganglia-thalamo-cortical circuitry both at the striatal and
at the thalamic level.
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Introduction
The clinical syndrome of Huntington’s disease (HD) is thought
to reﬂect dysfunction of the motor, associative and limbic basal-
ganglia-thalamo-cortical circuits (Joel, 2001). Timed psycho-
motor tests, such as the verbal ﬂuency task and the Stroop color
word test, are part of the Uniﬁed Huntington’s Disease Rating
Scale (UHDRS) and have been shown to be sensitive neuro-
psychological tools for the assessment of cognitive function in
HD in cross-sectional and longitudinal studies (Paulsen et al.,
2001; Snowden et al., 2001). The cerebral network activated
during verbal ﬂuency and Stroop tasks is well established and
includes prefrontal and thalamic regions (Ravnkilde et al.,
2002). Since the brunt of the neuronal loss in HD is found in
the striatum, i.e. the caudate nucleus and putamen (Vonsattel
et al., 1985; Vonsattel and DiFiglia, 1998), HD is generally taken
as a prime example of a disorder disrupting basal-ganglia-
thalamo-cortical circuitry at the level of the striatum (Joel,
2001). However, a disruption at levels other than the striatum
may well result in similar cognitive dysfunction (Van der Werf
et al., 2000; Schuurman et al., 2002). In particular, there is
convincing evidence from human lesion studies that the
thalamus is functionally important for performance in executive
tests. For example, in a recent study in 22 patients with
circumscribed vascular thalamic lesions, executive dysfunction-
ing was shown to result from lesions especially of the medial
dorsal, midline and intralaminar nuclei (Van der Werf et al.,
2003). In a study of nine patients with localized thalamic
strokes, performance in tasks probing executive function (e.g.
verbal ﬂuency) was found to be impaired in ﬁve subjects
(Annoni et al., 2003). For HD, a subgroup analysis of three-
dimensional magnetic resonance imaging (3-D MRI) in cogni-
tively severely impaired HD patients suggested that thalamic
atrophy might be associated with impaired cognitive functions
in HD (Kassubek et al., 2004a). The present study attempts to
clarify, using an observer-independent whole-brain-based ap-
proach, if cognitive performance in HD patients is correlated
with extrastriatal regional structural changes in volume-render-
ing MRI.
Patients and Methods
All data are given as arithmetic mean ± standard deviation. Forty-
four patients with genetically conﬁrmed HD in early clinical
stages [I and II according to the classiﬁcation of Shoulson
(Shoulson and Fahn, 1979)] were investigated (male/female
ratio 21/23; mean age 44.7 ± 10.7 years, range 25--66 years).
None of the patients were treated with psychotropic drugs at
the time of scanning. The mean number of CAG repeats in the
mutant allele was 45.5 ± 7.8. The age of onset was assessed as
the onset of motor signs; this information was obtained through
self-reports of patients and their relatives. The mean interval
between onset of motor symptoms and imaging was 5.1 ± 3.3
years. Patients were independently rated within one week prior
to the studies by two experienced neurologists, using the motor
score of the UHDRS and the Total Functional Capacity score
(TFC). On the motor subscore of the UHDRS, the mean value
was 24.1 ± 12.1. The TFC mean value was 10.9 ± 1.4.
The neuropsychological tests were performed in all 44 HD
patients and in 22 age-matched volunteers who constituted the
control group both here and in the morphometric MRI analysis.
The volunteers (male/female ratio 10/12; mean age 44.1 ± 16.9
years, range 25--68 years) had no history of central nervous
system disorders and displayed no symptoms and signs of
neurological and psychiatric diseases at the time of examina-
tion. They were matched to the patients with respect to years of
school education. Three timed psychomotor tests, which are
part of the UHDRS assessment battery, were used. First, a letter
ﬂuency test (LF, Controlled Oral Word Association test) was
administered to assess verbal ﬂuency by cueing the subjects
with a particular letter and asking them to generate as many
words as possible within 1 min (Benton and Hamsher, 1989).
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Second, the subjects performed the Stroop Color Word test to
assess selective attention, perceptual interference and informa-
tion processing speed (Treisman and Fearnley, 1969). This test
consists of reading words, naming colors and then naming the
color of ink of the words describing colors. The score is the
number of correctly identiﬁed items within 45 s for each
condition. Third, the Digit Symbol test (DS) from the Wechsler
Adult Intelligence Scale — Revised (WAIS-R) (Wechsler, 1981)
was employed under standard rules for administration, and the
test was scored according to WAIS-R criteria. The results of the
three tests (as scores adjusted for age, sex and education) were
summed to generate a global cognitive score as is generally used
for the cognitive subscore of the UHDRS. The summary score
(as an index of three seperate test among which one — the
Stroop test — is in itself composed of three subtests which tap
differentially on ‘executive functions’) is referred to as an
indicator of ‘executive functioning’. This is in line with the
(arguably loose) deﬁnition of ‘executive function’ in the clinical
literature to emphasize the fact that the common denominator
of all tests used is that some aspects of ‘executive function’ are
challenged.
High-resolution whole head 3-D MRI data of all patients were
collected on a 1.5 T clinical scanner (Siemens, Erlangen,
Germany). Images were acquired using a T1-weighted magne-
tization-prepared rapid-acquisition gradient echo sequence
(MP-RAGE) in the sagittal plane (160--180 partitions, repetition
time 9.7 ms, echo time 3.93 ms, ﬂip angle 15, matrix 256 3 256
mm2, ﬁeld of view 250 mm, voxel size 1 3 1 3 1 mm3). For
setting up an age-matched MRI normal data base, 3-D MRI data
of the above 22 healthy volunteers were acquired using the
same scanning protocol. All MRI data were processed in the
same way using methods implemented in the Statistical Para-
metric Mapping software (SPM99, Wellcome Department of
Imaging Neuroscience Group, London). Voxel-based morpho-
metric analysis (VBM) was performed according to the princi-
ples ﬁrst described by Ashburner and Friston (Ashburner and
Friston, 2000; Ashburner et al., 2003). The MRI data were
spatially normalized to map each structural MRI to a template in
the same standard 3-D stereotaxic space. Since the best
matched templates are created from the study group itself so
that the template can be considered as customized to the local
MRI scanner and disease population, the customized templates
in this study were created from the patients and controls (22
subjects each) in order to minimize the degree of non-linear
warping required, as previously described as the so-called
optimized protocol (Good et al., 2001, 2002). As a result of
non-linear spatial normalization, the volumes of certain brain
regions may grow, whereas others may shrink. In order to
preserve the amount of a particular tissue (gray matter) within
a voxel, a further processing step was incorporated. This
involved modulating voxel values by the Jacobian determinants
derived from the spatial normalization step (Ashburner and
Friston, 2000). Modulation effectively converts values of gray
and white matter concentration into gray matter mass, i.e.
rendering the inferences about the absolute amounts (volume)
of gray matter in a voxel as opposed to the relative amounts
(concentration) (Good et al., 2001). Further data processing
included automatic segmentation (into gray matter, white
matter, cerebrospinal ﬂuid) and smoothing (6 mm isotropic
Gaussian kernel). After smoothing, each voxel represents the
local average amount of gray matter in the surrounding region,
the size of which is determined by the smoothing kernel. The
gray matter images of the HD patients were then statistically
compared to the gray matter maps of the normal data base in
a parametric group analysis to detect whether each voxel had
a greater or lesser gray matter density than the controls. Within
this approach, the ﬂexible General Linear Model framework
allows effects to be partitioned between different explanatory
variables in a principled manner. This comparison between the
entire patient group and the control group was performed
within SPM99 as an analysis of covariance (ANCOVA) using the
individual cognitive sum scores for each patient and each
control. As nuisance variables, the individual values for age,
total gray matter volume, disease duration and UHDRS motor
score were included (being 0 for the latter two confounding
covariates in the controls); that way, these variables were
covaried out. Contrasts were chosen in such a way that the
interaction between group and cognitive performance was
examined.
As a different approach, a second ANCOVA was performed
within SPM99 using only the gray matter images of the patients
and individual cognitive scores (including age, total gray matter
volume, UHDRS motor score and disease duration as confound-
ing covariates). Finally, an additional ANCOVA was calculated
within SPM99 for control purposes as a voxel-based comparison
between the patient group and the control group using the
individual UHDRS motor scores for the patients (and 0 for
controls) as covariates without including the cognitive scores.
Resulting parametric maps were transformed to normal
distribution. All data presented were corrected for multiple
comparisons by the error correction implemented in SPM99
and were thresholded at a P-value P < 0.001, representing
a conservative estimate. The coordinates of signiﬁcant foci
derived from the Montreal Neurological Institute template were
transformed to the 3-D standard coordinate system of Talairach
and Tournoux for anatomical identiﬁcation using the appropri-
ate algorithm (Brett et al., 2002). The identiﬁcation of neuro-
anatomical regions, e.g. speciﬁc thalamic subnuclei, was based
on these stereotaxic coordinates as provided by the MNI or
Talairach 3-D grid, respectively, gained from the voxel clusters
with maximal Z-values (at P < 0.001, corrected).
To further control for possible effects of atrophy on a group
analysis of spatially normalized brains, an additional processing
step was included: after analysis, the signiﬁcant voxel clusters
were registered back onto individual subjects’ brains. For that
purpose, the spatial deformation ﬁelds applied during the spatial
normalization of individual brain data were written out. These
deformation ﬁelds were then inverted and consecutively
applied to the signiﬁcant voxel clusters. These inversely
normalized voxel clusters were then superimposed onto the
individual, original structural MRI data (i.e. which were not
spatially normalized and thus in native space). This procedure
was performed for all patients separately and anatomical local-
izations of the thalamic clusters were checked for consistency.
In addition, the brain parenchymal fractions (BPF) were
calculated from the segmented 3-D MRI data for all HD patients
according to a previously described largely automated protocol
(Kassubek et al., 2003, 2004b). BPF, deﬁned as the proportion of
brain parenchymal volume to total intracranial volume, is a size-
normalized quantiﬁcation of brain volume and may serve as
a marker of global brain atrophy if compared to age-matched
healthy volunteers (Juengling and Kassubek, 2003). Further
statistical analysis was performed using the Statistical Package
for the Social Sciences software (SPSS, Version 9.0, Chicago, IL).
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Results
Mean values in all three timed psychomotor tests indicated
moderate impairment in the cohort of patients compatible with
early stages of HD. The mean value of the summed cognitive
score was 196 ± 63 (range 120--364). In the control group, the
mean cognitive sum score was 303 ± 47 (range 235--389).
Differences between the two groups were statistically signiﬁ-
cant both for each subscore and for the summed score
(P < 0.001, Mann--Whitney U-test). The values of the summed
cognitive scores and all subtests in HD patients and controls are
displayed in Table 1.
Comparing HD patients and controls by use of VBM, including
cognitive performance in an ANCOVA, regional decreases of
gray matter density indicative of atrophy were found at high
signiﬁcance levels (thresholded at P < 0.001, corrected for
multiple comparisons). Locally increased concentrations of gray
matter were not found at P < 0.001. Several areas of regional
decrease in gray matter density were observed (Fig. 1A). The
largest voxel clusters of signiﬁcantly decreased gray matter
density were localized in the caudate nucleus and in the
putamen bilaterally and almost symmetrically, in agreement
with the results of a previous VBM study in HD patients
(Kassubek et al., 2004a) and neuropathological ﬁndings
(Vonsattel and DiFiglia, 1998). Outside the striatum, gray matter
density was markedly decreased bilaterally in the thalamus
(P < 0.001, corrected; Fig. 1A--C). In addition, small voxel
clusters of decreased gray matter density were localized in the
opercula and in the paracentral lobule. In Figure 1A, maximum
intensity projections of all areas with signiﬁcantly decreased
gray matter density are shown as an overlay on the SPM standard
glass brain template.
The thalamic gray matter changes were fairly symmetrical;
they covered relatively large subregions of the thalamus, with
two distinct intrathalamic voxel clusters. [Thalamic nuclear
divisions are named according to the Jones nomenclature
(Macchi and Jones, 1997).] A ﬁrst cluster was found in the
medial aspects of the thalamus, extending ventrally towards the
hypothalamus (Fig. 1B and left part of Fig. 1C). The Talairach
coordinates (x, y, z) of the area within the cluster displaying the
highest signiﬁcance values were 6 (--18) 2, indicating a localiza-
tion within the dorsomedial nuclear complex (DM). A second,
more laterally and ventrally localized cluster was identiﬁed (Fig.
1B and right part of Fig. 1C); the Talairach coordinates of the
area within the cluster displaying the highest signiﬁcance values
were 15 (–14) 3, indicating a localization within the ventro-
lateral complex (VLa). This cluster also covered in part the areas
of the centromedian/parafascicular complex (CM; Fig. 1B). The
areas of highest signiﬁcance within the thalamus were localized
within the ventrolateral group of both sides. The gray matter
intensity values at these centers differed signiﬁcantly between
patients and controls (P < 0.001; Mann--Whitney U-test, SPSS).
The ANCOVA within SPM99 using only the gray matter images
of the patients showed a nearly identical result pattern with
regionally decreased gray matter in the striatum and in the
thalamus including CM/VLa and DM (Fig. 2). The SPM-based
analysis comprising the comparison between patients and
controls using only the motor scores as covariates, which had
been performed for control purposes, demonstrated signiﬁcant
gray matter changes mainly in striatal areas, but not in the
thalamus (results not shown).
Following the inverse transformation of statistically signiﬁ-
cant clusters, the overlay onto each individual patient’s brain in
native space demonstrated in all cases that thalamic changes
were localized essentially in the same thalamic subnuclei as
described for the group analysis. An illustrative example is given
in Figure 3, showing signiﬁcant gray matter changes in the
dorsomedial as well as in the ventrolateral thalamic nuclear
complexes in an individual HD patient.
Next, we analyzed the interdependence of the various factors
included in the ANCOVA. The bivariate correlations, calculated
between the different factors using SPSS, demonstrated a signiﬁ-
cant correlation between cognitive and motor scores
(P < 0.001). Correlations between age and cognitive or motor
scores, respectively, and disease duration and cognitive or
motor scores, respectively, were not statistically signiﬁcant.
Mean BPF in the HD patients (mean age 44.7 years) was
0.7629 ± 0.0303 (range 0.6980--0.8338). This value was signiﬁ-
cantly decreased both in comparison to themean BPF of the age-
matched normal data base used for the VBM analysis (0.8292 ±
0.0392) and compared to themean BPF value of healthy controls
at ages 40--49 years in a previous study (0.8295 ± 0.0055)
(Kassubek et al., 2003), indicating substantial global cerebral
atrophy. A bivariate correlation analysis between BPF values and
overall cognitive performance (including performance in the
cognitive subtests separately) did not disclose statistically
signiﬁcant correlations (SPSS).
Discussion
In this voxel-based morphometric MRI study, which was
designed to identify areas exhibiting regional atrophy depen-
dent on cognitive deﬁcits, decreases of gray matter density in
the dorsomedial (DM) and centromedian/ventrolateral (CM/
VLa) nuclear groups of the thalamus bilaterally were identiﬁed
to co-vary with cognitive performance, but not with other
clinical features, e.g. motor impairment. This result suggests
that structural changes outside the striatum contribute in an
important way to a decline of psychomotor function in HD and
indicates that the clinical phenotype of HD reﬂects a multi-
system neurodegeneration.
From a methodological point of view, the VBM approach
allows for a whole-brain based analysis without a priori
assumptions about areas of alteration, in contrast to region-of-
interest based approaches. Inherent to VBM, however, there are
several properties that may render the interpretation of VBM
studies challenging. The individual features of brains, i.e. gyral
and sulcal patterns, are not preserved but blurred in the VBM
technique by the steps of normalization to a template and
smoothing — although the anatomical variability across indi-
viduals may be difﬁcult to interpret by region-of-interest
techniques as well (Steinmetz and Seitz, 1991). Furthermore,
the accuracy of registration in terms of spatial normalization in
Table 1
Scores of timed psychomotor tests (mean ± SD; single tests separately and summed score)
for HD patients (n 5 44) and controls (n 5 22)
LF DS Stroop Sum score
Color naming Word reading Interference
HD patients 22 ±11 29 ±15 48 ± 16 66 ± 20 30 ± 15 196 ± 63
Controls 30 ± 9 45 ± 13 75 ± 12 102 ± 12 41 ± 12 303 ± 47
P value P\ 0.001 P\ 0.001 P\ 0.001 P\ 0.001 P\ 0.001 P\ 0.001
LF, letter fluency test; DS, digit symbol test. Statistical significance of the differences between
the groups calculated by Mann--Whitney U-test.
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the presence of atrophy is a problem inherent in VBM. The non-
linear spatial transformations used do not attempt to match
every single structure in the brain exactly, but rather attempt to
minimize global brain shape differences. Nevertheless, any
differences detected by VBM must be caused by systematic
differences in the anatomy of these structures between the
groups of subjects to be compared. Several recent studies
reported on the application of VBM to markedly atrophic brains
(Grossman et al., 2004), demonstrating that the presence of
atrophy per se does not preclude a valid analysis using VBM
provided that a number of steps are performed to attenuate the
potentially confounding effects of atrophy to the normalization
process. In the present study, therefore, customized templates,
taking into account the properties of the local MRI scanner and
the disease population, were created from patients and controls
in order to minimize the degree of non-linear warping required,
as previously described by Good et al. (2001) as the so-called
optimized protocol. By this approach, a further potential
problem is addressed: the gray--white contrast of the thalamus
is poor in T1-weighted images. The classiﬁcation of gray and
white tissue in the segmentation process within SPM is based on
a prior probability map, reducing misclassiﬁcation problems in
regions with lower gray--white contrast. To further attenuate
these misclassiﬁcation errors, we used customized age- and
disease-matched priors. The application of this protocol should
therefore increase the applicability of the VBM approach in the
analysis of diseased brains.
Our demonstration of thalamic volume alterations dependent
on cognitive performance in early stages of HD appears at ﬁrst
glance to be at odds with recent studies using high-resolution
MRI in which no signiﬁcant atrophy was observed in the region
of the thalamus. For example, in a 3-D MRI study using VBM,
highly signiﬁcant regional gray matter atrophy was found
bilaterally in striatal areas, whereas extrastriatal gray matter
changes were restricted to a small set of areas not involving the
thalamus (Kassubek et al., 2004a). Rosas et al. reported
a widespread extrastriatal involvement in 18 HD patients using
a region-of-interest-based approach of 3-D MRI analysis (Rosas
et al., 2003), but the thalamus appeared to be spared with
volumes of 100% relative to normal controls. In addition,
a functional imaging study using single photon emission
computed tomography (Harris et al., 1996) could not demon-
strate thalamic abnormalities in groups of patients with early
HD. All these studies lumped together patients with different
degrees of cognitive impairment. Cognitive deﬁcits in early HD
patients, although they inevitably develop, vary considerably in
severity; therefore, subtle regional structural changes associated
with cognitive decline might be missed in imaging studies if
unselected large groups of HD patients in early stages are
investigated. In the present study, impairment of executive
functions was speciﬁcally interrogated by three neuropsycho-
logical tests, and the test scores in these timed psychomotor
tasks were used for an ANCOVA within the morphometric
comparison between patients and controls in the sense of
Figure 1. Results of voxel-based morphometric comparison between HD patients (n 5 44) and controls (n 5 22) (ANCOVA including individual cognitive performances). (A)
Maximum intensity projection of all areas with significantly decreased gray matter (P\0.001, corrected for multiple comparisons) in the SPM group analysis as an overlay on the
SPM standard glass brain template (sagittal, axial and coronal view). The local maximum in the right thalamus (located in the ventrolateral nucleus) is marked by the red arrowhead.
(B) Display of the areas showing significantly decreased gray matter (P\ 0.001, corrected) superimposed on the standard template as a range of slices in coronal view, covering
the brain from stereotaxic coordinates y523 to y512 (slice thickness 1 mm). Z-score is indexed by the colorbar. (C) Enlarged single slices in axial view showing the overlay of
significant voxel clusters localized in the thalamus onto the SPM template, on the left at the level of the dorsomedial nucleus (z5 2) and on the right at the level of the ventrolateral
nuclear group (z 5 3), each marked by crosshairs. Z-score is indexed by the colorbar.
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Figure 1. Continued.
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voxel-based lesion-symptom mapping as proposed by Bates
et al. (2003).
The demonstration of thalamic volume loss in the present
VBM analysis converges with neuropathological observations
(Heinsen et al., 1996, 1999), indicating neuronal loss within the
thalamus in end-stage HD patients at autopsy. At postmortem,
two thalamic subregions appear to be most prominently
affected: ﬁrst, the centromedian/parafascicular nuclei (CM)
and second, the dorsomedial nuclei (DM) (Heinsen et al.,
1999). In addition, the ventrolateral thalamic subregion, which
relays basal ganglia output, may display volume loss (Dom et al.,
1976). The same subnuclei which demonstrated to exhibit the
most profound alterations in neuropathological studies of end-
stage HD brains (well in access to the global atrophic changes in
the thalamus or the brain overall) were shown to be altered in
our observer-independent hypothesis-free VBM analysis based
on the Talairach coordinates of the maxima of signiﬁcant voxel-
clusters and therefore supports our interpretation that these
thalamic changes develop as a feature of HD.
The connectivity of the affected thalamic subnuclei lends
further plausibility to the notion that the alteration of the
thalamus in HD has functional implications. CM as an efferent
thalamic nucleus mainly projects to the striatum (Morel et al.,
1997); a retrograde process of degeneration may therefore play
a role in the degeneration of CM in HD. In contrast, DM is not
synaptically connected to the striatum, but projects preferen-
tially to prefrontal cortical areas. Although several areas in the
thalamus might account for executive deﬁcits, especially DM
(which was shown to be affected in our study) seems to be an
important relay station in executive function as demonstrated
by lesion studies (Schuurman et al., 2002; Van der Werf et al.,
2003).
It is unknown when during the course of HD thalamic
degeneration sets in, resulting in volume changes and eventually
leading to neuronal loss. In a previous VBM study in 18
presymptomatic HD gene carriers (Thieben et al., 2002), gray
matter changes in the tectum of the midbrain were reported
among other ﬁndings which extended into the left medio-dorsal
thalamic nucleus. These ﬁndings are compatible with our data
since the mutation-positive subjects in the study by Thieben
et al. showed some gray matter alterations in the thalamic area
(small-volume-corrected P = 0.003, only in the left hemisphere)
while scoring signiﬁcantly lower than controls in, for example,
the Stroop word score. A deﬁnite answer to the question when
in the course of HD thalamic changes begin to be apparent
obviously requires a longitudinal study in mutation carriers well
before the onset of clinically apparent disease; a large-scale
longitudinal study (‘PREDICT-HD’) was launched in 2001 by the
Huntington Study Group to address questions of this kind
(http://www.huntington-study-group.org). The data of the
present study suggest that already in HD stages I and II thalamic
alterations can occur, in particular in patients displaying
prominent impairment in timed psychomotor tasks. These
ﬁndings imply that HD is a true multisystem disorder which
appears to affect regions outside the striatum at a time when
overall functional impairment does not yet preclude indepen-
dent living.
In addition, the evidence for both striatal and thalamic
atrophy in the present study suggests that the basal-ganglia-
thalamo-cortical loops engaged in verbal ﬂuency and Stroop
tasks may be disrupted at several levels in HD. Our study
demonstrates disruptions at the level of both striatum and
Figure 2. Results of voxel-based morphometric analysis in HD patients (n5 44) using
ANCOVA including individual cognitive performances. Enlarged single slice in axial view
showing the overlay of significant voxel clusters localized in the thalamus onto the SPM
template, at a level demonstrating both the dorsomedial nucleus and the ventrolateral
nuclear group (z 5 2). Z-score is indexed by the colorbar.
Figure 3. Overlay of significant voxel clusters onto structural 3-D MRI of an individual HD patient after inversed normalization, i.e. in native space. Significant voxels in the thalamus
are localized both in the dorsomedial and in the ventrolateral thalamic nuclear complexes. Z-score is indexed by the colorbar. Note that the left--right orientation is reversed after
inversed normalization.
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thalamus. There are several arguments in favor of an important
role of thalamic atrophy in cognitive dysfunction present in the
HD patients: ﬁrst, thalamic gray matter changes were only
observed when analyzing brain morphology with cognitive
functions as a covariate; striatal changes, however, occur as
a robust ﬁnding in a morphometry without additional co-
variance (although it is clear that the possibility that striatal
alterations in themselves are sufﬁcient to cause the cognitive
deﬁcits observed in HD patients cannot be ‘ruled out’ by the
data presented). Second, the results of the additional analyses
performed support this interpretation: (i) the within-group
analysis of the HD patients with cognitive score as covariates
demonstrates the same pattern of thalamic grey matter changes;
(ii) in comparison, an analysis using clinical parameters other
than cognitive score (e.g. motor score) as covariates demon-
strates no thalamic grey matter changes. Concerning the other
extrastriatal alterations (i.e. the circumscribed cortical atrophy
localized in the opercula bilaterally and in the right paracentral
lobule) disclosed by our analysis, it is of note that (i) these
alterations were considerably less robust (with respect to the
P-values in this study) than the thalamic changes reported and
(ii) that we observed these circumscribed cortical changes —
like the striatal atrophy— as well in analyses not using cognitive
functions as a covariate. All these points support the view that
localized thalamic atrophy in HD does have a functional
correlate, i.e. contributes to cognitive impairment. Lastly, it is
worth mentioning that the localization of the atrophy within
the thalamus (i.e. affecting the medio-dorsal and the ventrolat-
eral subnuclei) is plausible in view of what is known about the
connectivity (and hence functional role) of the thalamic
subregions disclosed by our analysis. The results of lesion
studies emphasize this point, i.e. the observation that impair-
ment in verbal ﬂuency and Stroop tests reminiscent of the
pattern found in HD can be brought about by isolated thalamic
lesions, e.g. circumscribed infarct (Van der Werf et al., 2000).
To our minds, the fact that no prefrontal cortical areas were
shown to display signiﬁcant atrophy in this VBM analysis does
not imply that these areas are structurally intact — neuropath-
ological studies (e.g. DiFiglia et al., 1997; Gutekunst et al.,
1999), as well as MRI-based studies (Rosas et al., 2002) provided
evidence to the contrary — but indicates that cortical atrophy is
variable and does not develop with the same robustness as in
striatal and thalamic regions. As a note aside: with respect to
thalamic changes, we qualify the thalamic atrophy in cognitively
impaired HD patients as ‘robust’ based on the high P value
associated with thalamic alterations; we do not want to imply by
‘robust’ that multiple other MRI-based studies on HD came to
identical conclusions — on the contrary, further independent
studies are needed to either conﬁrm or refute our ﬁndings.
Furthermore, the impairment in executive functions appears
to co-vary speciﬁcally with regional atrophy in both striatal and
thalamic areas. In the present study [as well as in a 3-D MRI
study on 70 HD patients (Kassubek et al., 2004b)], no
signiﬁcant correlation between clinical scores and the BPF
values was found. This observation indicates that there is no
correlation between the impairment of executive functions
and overall gross brain atrophy and underscores that regional
atrophy appears to underlie diminished cognitive abilities
in HD.
Lastly, our ﬁndings have implications for the use of HD
patients to infer basal ganglia function. In numerous studies,
results obtained in HD patients were interpreted solely as
a reﬂection of basal ganglia dysfunction (e.g. Lauterbach et al.,
1998; Richer et al., 2002). Our results caution against this
interpretation since the patients who are impaired in executive
tests display ‘double’ lesions both at the striatal and the thalamic
level. Our results suggest that neuropsychological tools like
verbal ﬂuency and Stroop tests are useful for probing the
function of basal-ganglia-thalamo-cortical circuitry, but do not
allow to infer speciﬁc sites of disruption.
Notes
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